SAFRICA-HEALTH-VIRUS-HIV-AIDS

Kegoratile Aphane sits in the waiting area as she waits to receive a dose of Lenacapavir at the Phedisong clinic in Ga-Rankuwa, north-west of Pretoria, on December 2, 2025. Lenacapavir, a drug taken twice a year that has been shown to reduce the risk of HIV transmission by more that 99.9% was administered as part of an implementation study by a Wits University research unit which is funded by the international health agency Unitaid. (Photo by Ihsaan Haffejee / AFP via Getty Images)

SAFRICA-HEALTH-VIRUS-HIV-AIDS
Kegoratile Aphane sits in the waiting area as she waits to receive a dose of Lenacapavir at the Phedisong clinic in Ga-Rankuwa, north-west of Pretoria, on December 2, 2025. Lenacapavir, a drug taken twice a year that has been shown to reduce the risk of HIV transmission by more that 99.9% was administered as part of an implementation study by a Wits University research unit which is funded by the international health agency Unitaid. (Photo by Ihsaan Haffejee / AFP via Getty Images)
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesSAFRICA-HEALTH-VIRUS-HIV-AIDS, News PhotoSAFRICA-HEALTH-VIRUS-HIV-AIDS, News PhotoSAFRICA-HEALTH-VIRUS-HIV-AIDS Get premium, high resolution news photos at Getty ImagesProduct #:2249015027
$499$175
Getty Images
In stock

DETAILS

Credit: IHSAAN HAFFEJEE / Contributor

Getty Images editorial coverage is captured by expert trusted visual journalists. Learn more about our editorial policies.

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
Editorial #:
2249015027
Collection:
AFP
Date created:
December 02, 2025
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_86VN3UB
Max file size:
6000 x 4000 px (20.00 x 13.33 in) - 300 dpi - 5 MB